MUDr. Jiří Tomášek, Ph.D.
Assistant professor, Comprehensive Cancer Care Department
Total number of publications: 208
2018
-
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
NEUROENDOCRINOLOGY, year: 2018, volume: 107, edition: 3, DOI
-
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis
CANCER SCIENCE, year: 2018, volume: 109, edition: 1, DOI
-
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
NEUROENDOCRINOLOGY, year: 2018, volume: 106, edition: 3, DOI
2017
-
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncology, year: 2017, volume: 18, edition: 10, DOI
-
Maligní nádory tenkého střeva
Rozhledy v chirurgii, year: 2017, volume: 96, edition: 6
-
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review
BMC Cancer, year: 2017, volume: 17, edition: 798, DOI
-
Postavení adjuvantní chemoterapie po neoadjuvantní chemoradioterapii u karcinomu rekta.
Klinická onkologie, year: 2017, volume: 2017, edition: S92
-
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
JOURNAL OF GASTRIC CANCER, year: 2017, volume: 17, edition: 2, DOI
-
Příčiny malnutrice.
Klinická onkologie, year: 2017
-
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI